This contract opportunity involves the supply of a range of medical products, including medications, infusion fluids, inhalation agents, surgical linens, and medical devices. The procurement is divided into fourteen packages: Package I covers general medications; Package II focuses on medications; P
Tender closed on 2 Oct 2025. Awaiting award.
No single supplier dominates the field.
In healthcare medical, INSTITUTE OF PHYSIOLOGY AND PATHOLOGY OF HEARING has awarded 4 contracts to 4 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract opportunity involves the supply of a high-resolution computed tomography (CT) scanner, including all necessary equipment, installation services, and modifications to the facility. The aim is to enhance medical imaging capabilities within the health sector. Suppliers are invited to prov
This contract opportunity involves the procurement of medical materials, specifically implants, for the health sector. The buyer, the Institute of Physiology and Pathology of Hearing in Poland, is seeking suppliers to provide these essential medical products. The total value of the contract is appro
This contract involves the procurement of 200 sets of medical processors. The total value of the contract is €7,400,000. The buyer is the Institute of Physiology and Pathology of Hearing in Poland. This opportunity is aimed at suppliers who can provide high-quality medical processing equipment essen
Ireland is seeking a qualified occupational health services provider to deliver comprehensive workplace health assessments, medical surveillance, and occupational health advisory services.
NHSBT seeks suppliers of colour-coded EDTA sample tubes with bar-code labels to support testing of 1.5 million annual blood and tissue donations across two English facilities.
BHRUT seeks an outsourced dermatology service provider to treat 800 waiting list patients from November 2026 to March 2027 (£520,000 contract value).
A competitive NHS framework agreement enabling the supply of unlicensed imported medicines to healthcare organisations and eligible public bodies, subject to strict regulatory compliance and quality assurance standards.
